Skip to content
DataLookout
Menu

NCT07930481

Non-invasive Spinal Stimulation for Gait in Genetic Spasticity

StatusEnrolling by Invitation
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Spastic Paraplegia Rating Scale (SPRS)
Timeframe: This assessment will be performed at baseline, and again at weeks 2, 4, 8, 10, 12, and 16.

Secondary (12)

Lower extremity dynamometry
25-foot timed walk test
2-minute walk test
Hmax/Mmax ratio
Mini-Balance Evaluation Systems Test (Mini-BEST)
Show 7 moreShow less
Patient Global Impression of Change (PGIC)
Clinician Global Assessment of Change (CGIC).
Neuropathic Bladder Symptom Score (NBSS)
Neuropathic Bowel Dysfunction Scale (NBDS)
Neuropathic Pain Symptom Inventory (NPSI)
Patient Reported Outcome Measurement Information Systems (PROMIS) Item Bank v1.0 - Pain Interference - Short Form 8a
Modified Ashworth Scale (MAS)

Arms and interventions

Sham StimulationSham comparator

Participants will undergo intensive locomotor training combined with sham stimulation

Active StimulationActive comparator

Participants will undergo active stimulation combined with intensive locomotor training.

Devices: Transcutaneous spinal cord stimulation, Sham transcutaneous spinal cord stimulation

Sites

1 site in 1 country

  • John Wallace Hall, Amplify Movement and Performance LaboratorySeattle, Washington, United States